Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Urol Oncol. 2019 Jul 19;37(11):813.e1–813.e9. doi: 10.1016/j.urolonc.2019.06.015

Figure 1:

Figure 1:

Consort Diagram.

Levels of Evidence based on OncoKB precision Oncology knowledge Base There are currently no Level 1 or 2 precision oncology approaches for prostate cancer. Out of the 77 patients with Foundation One Testing, 7 patients(9%) received targeted therapy.